Our findings together with other clinical and mouse studies, reveal that COUP-TFII gene mutations are strongly associated with growth retardation, CHD, CDH, congenital coloboma, and postnatal viability27,28,34–37,51,60,61. The gene discussed is NR2F2; the disease is coronary artery disorder.